February 12, 2020

Allena Pharmaceuticals

Allena Pharmaceuticals Announces Streamlined Design for URIROX-2, Second Pivotal Clinical Trial of Reloxaliase for Enteric Hyperoxaluria

February 06, 2020

Jounce Therapeutics

Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announces Research Collaboration with NanoString Technologies

February 06, 2020

Blueprint Medicines

Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor

February 05, 2020

Magenta Therapeutics

Magenta Therapeutics Expands Leadership Team, Appoints Kristen Stants as Chief People Officer and Li Malmberg as Senior Vice President, Head of Manufacturing

February 04, 2020

Relay Therapeutics

Relay Therapeutics Appoints Dr. James Nichols to Lead Expansion into Genetic Diseases

Load More

Sign up for weekly portfolio news.